Endocrine

, Volume 13, Issue 3, pp 325–328 | Cite as

Thyroid-associated ophthalmopathy in black South Africans with Graves' disease

Relationship to serum antibodies reactive against eye muscle and orbital connective tissue autoantigens
  • Barry J. Joffe
  • Vanessa R. Panz
  • Masayo Yamada
  • Jack R. Wall
Article

Abstract

The prevalence of hyperthyroidism owing to Graves1 disease is increasing among urban black South Africans. Thyroid-associated ophthalmopathy is often observed in this context, but its pathogenesis remains unclear. No close relationship has been noted between antiflavoprotein (Fp) antibodies or thyrotropin receptor antibodies and ocular involvement in black patients. We measured serum antibodies against eye muscle and orbital connective tissue antigens in black patients with Graves1 disease, correlating them with eye signs. Of 11 patients with clinical ophthalmopathy, 2 (18%) had antibodies against collagen type XIII, 3 (27%) against flavine adenine dinucleotide (FAD), 1 (9%) against Fp, and 4 (35%) against G2s. Antibody prevalences in eight patients without clinical ophthalmopathy were 12.5% for collagen XIII, 12.5% for FAD, 25% for Fp and 0% for G2s. These differences were not statistically significant. None of the individual mean antibody levels were significantly different between the two subgroups of thyrotoxic patients. Serum antibody levels were negative in 10 black South African controls. In summary, eye muscle and orbital connective tissue antibodies were found in small proportions of patients with Graves1 disease with no close relationship of any antibody to eye signs. Thus, a substantial proportion of black South Africans with overt clinical ophthalmopathy remains in whom currently availabe serologic tests are unhelpful for screening and laboratory confirmation.

Key Words

Graves1 disease ophthalmopathy flavoprotein G2s collagen XIII 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kalk, W. J. (1981). East Afr. Med. J. 58, 109–116.PubMedGoogle Scholar
  2. 2.
    Mengistu, M. (1993). Ethiop. Med. J. 3, 25–36.Google Scholar
  3. 3.
    Modebe, O. (1995). Afr. J. Med. Med. Sci. 24, 347–351.PubMedGoogle Scholar
  4. 4.
    Zouvanis, M., Panz, V. R., Kalk, W. J., and Joffe, B. I. (1998). J. Endocrinol. Invest. 21, 771–774.PubMedGoogle Scholar
  5. 5.
    Joffe, B. L., Gunji, K., Panz, V., Ackrell, B., et al. (1998). Thyroid 8, 1023–1027.PubMedCrossRefGoogle Scholar
  6. 6.
    Panz, V. R., Raal, F. J., Wall, J. R., and Joffe, B. I. (2000). Endocrine 12, 21–24.PubMedCrossRefGoogle Scholar
  7. 7.
    Salvi, M., Miller, A., and Wall, J. R. (1988). FEBS Lett. 232, 135–139.PubMedCrossRefGoogle Scholar
  8. 8.
    Wu, Y. I., Clarke, E. M., and Shepherd, P. (1998). Thyroid 8, 167–174.PubMedCrossRefGoogle Scholar
  9. 9.
    Kubota, S., Gunji, K., Ackrell, B. A., et al. (1998). J. Clin. Endocrinol. Metab. 83, 443–447.PubMedCrossRefGoogle Scholar
  10. 10.
    Gunji, K., De Bellis, A., Kubota, S., et al. (1999). J. Clin. Endocrinol. Metab. 84, 1255–1262.PubMedCrossRefGoogle Scholar
  11. 11.
    Gunji, K., De Bellis, A., Li, A. W., et al. (2000). J. Clin. Endocrinol. Metab., 85, 1641–1647.PubMedCrossRefGoogle Scholar
  12. 12.
    Pihlajaniemi, T. and Rehn, M. (1995). Prog. Nucleic Acid Res. Mol. Biol. 50, 225–262.PubMedCrossRefGoogle Scholar
  13. 13.
    Hagg, P., Rehn, M., Huhtala, P., Vaisanen, T., Tamminen, M., and Pihlajaniemi, T. (1998), J. Biol. Chem. 273, 15,590–15,597.Google Scholar
  14. 14.
    Wall, J. R., Blanchard, M. E., West, K., and Pihlajaniemi, T. (1999). Paper presented at the 72nd Annual meeting of the American Thyroid Association (abstract). Palm Springs, FL.Google Scholar
  15. 15.
    Soloyeva, T. P. (1989). Orbit 3, 193–198.Google Scholar
  16. 16.
    Panz, V. R., Kalk, W. J., Zouvanis, M., and Joffe, B. I. (2000). Diabetic Med., 17, 524–527.PubMedCrossRefGoogle Scholar
  17. 17.
    Committees of the American, European, Asia-Oceania, and Latin America Thyroid Associations. (1992). Thyroid 2, 235–236.Google Scholar
  18. 18.
    Miller, A., Sikorska, H., Salvi, M., and Wall, J. R. (1986). Acta Endocrinol. 113, 514–522.PubMedGoogle Scholar
  19. 19.
    Kapusta, M., Salvi, M., Triller, H., Gardini, E., Bernard, N., and Wall, J. R. (1990). Autoimmunity 7, 33–40.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2000

Authors and Affiliations

  • Barry J. Joffe
    • 2
  • Vanessa R. Panz
    • 2
  • Masayo Yamada
    • 1
  • Jack R. Wall
    • 1
  1. 1.Department of MedicineQueen Elizabeth II Health Sciences CentreHalifaxCanada
  2. 2.Carbohydrate and Lipid Metabolism Research GroupUniversity of the Witwatersrand Medical SchoolJohannesburgSouth Africa

Personalised recommendations